Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access February 13, 2014

CEACAM5 is correlated with Angio/Lymphangiogenesis of Prostatic Lesions

  • Jie-ke Yan EMAIL logo , Yu-zhen Wang , Chuan Tian , Shuang-de Liu , Cheng-jun Zhou , Wei-dong He , Xiao-li Liu , Dong-sheng Xu , Rong-mei Zhang , Hong-wei Wang and Shengtian Zhao
From the journal Open Medicine


[1] Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481 in Google Scholar

[2] Taheri M, Saragovi U, Fuks A, Makkerh J, Mort J, Stanners CP. Self recognition in the Ig superfamily. Identification of precise subdomains in carcinoembryonic antigen required for intercellular adhesion. J Biol Chem. 2000 Sep 1;275(35):26935–26943 10.1016/S0021-9258(19)61463-8Search in Google Scholar

[3] Ordonez C, Screaton RA, Ilantzis C, Stanners CP. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res. 2000 Jul 1;60(13):3419–3424 Search in Google Scholar

[4] Ilantzis C, DeMarte L, Screaton RA, Stanners CP. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia. 2002 Mar–Apr;4(2):151–163 in Google Scholar PubMed PubMed Central

[5] Chan CH, Cook D, Stanners CP. Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice. Carcinogenesis. 2006 Sep;27(9):1909–1916 in Google Scholar PubMed

[6] Chan CH, Camacho-Leal P, Stanners CP. Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family memberexpression in transgenic mice. PLoS One. 2007 Dec 26;2(12):e1353 in Google Scholar PubMed PubMed Central

[7] Hostetter RB, Campbell DE, Chi KF, Kerckhoff S, Cleary KR, Ullrich S, Thomas P, Jessup JM. Carcinoembryonic antigen enhances metastatic potential of human colorectal carcinoma. Arch Surg. 1990 Mar;125(3):300–304 in Google Scholar PubMed

[8] Hashino J, Fukuda Y, Oikawa S, Nakazato H, Nakanishi T. Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen. Clin Exp Metastasis. 1994 Jul;12(4):324–328 in Google Scholar PubMed

[9] Zareba P, Zhang J, Yilmaz A, Trpkov K. The impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice. Histopathology. 2009 Oct;55(4):384–391 in Google Scholar PubMed

[10] Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992 Dec 16;84(24):1875–1887 in Google Scholar PubMed

[11] Ferro M, Bruzzese D, Perdonà S, Mazzarella C, Marino A, Sorrentino A, Di Carlo A, Autorino R, Di Lorenzo G, Buonerba C, Altieri V, Mariano A, Macchia V, Terracciano D. Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers. Clin Chim Acta. 2012 Aug 16;413(15–16):1274–1278 in Google Scholar PubMed

[12] Terracciano D, Bruzzese D, Ferro M, Mazzarella C, Di Lorenzo G, Altieri V, Mariano A, Macchia V, Di Carlo A. Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading. Prostate. 2012 Jan;72(1):100–107 in Google Scholar

[13] Duxbury MS, Matros E, Clancy T, Bailey G, Doff M, Zinner MJ, Ashley SW, Maitra A, Redston M, Whang EE. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions. Ann Surg. 2005 Mar;241(3):491–496 in Google Scholar

[14] Glinsky GV. Anti-adhesion cancer therapy. Cancer Metastasis Rev. 1998 Jun;17(2):177–185 in Google Scholar

[15] Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene. 2002 Dec 12;21(57):8683–8695 in Google Scholar

[16] Zhou H, Stanners CP, Fuks A. Specificity of anticarcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion. Cancer Res. 1993 Aug 15;53(16):3817–3822 Search in Google Scholar

[17] Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res. 2004 Jun 1;64(11):3987–3993 in Google Scholar

[18] Yoshioka T, Masuko T, Kotanagi H, Aizawa O, Saito Y, Nakazato H, Koyama K, Hashimoto Y. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development. Jpn J Cancer Res. 1998 Feb;89(2):177–185 in Google Scholar

[19] Thomas P, Gangopadhyay A, Steele G Jr, Andrews C, Nakazato H, Oikawa S, Jessup JM. The effect of transfection of the CEA gene on the metastatic behavior of the human colorectal cancer cell line MIP-101. Cancer Lett. 1995 May 25;92(1):59–66 in Google Scholar

[20] Charbonneau J, Stanners CP. Role of carbohydrate structures in CEA-mediated intercellular adhesion. Cell Adhes Commun. 1999;7(3):233–244 in Google Scholar

[21] Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as a intercellular adhesion molecule. Cell. 1989 Apr 21;57(2):327–334 in Google Scholar

[22] Oikawa S, Inuzuka C, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H. Cell adhesion activity of non-specific cross-reacting antigen(NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem Biophys Res Commun. 1989 Oct 16;164(1):39–45 in Google Scholar

[23] Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol. 2012 Mar;61(3):480–487 in Google Scholar PubMed

[24] Yamamura T, Tsukikawa S, Yamada K, Yamaguchi S. Morphologic analysis of microvessels in colorectal tumors with respect to the formation of liver metastases. J Surg Oncol. 2001 Dec;78(4):259–264 in Google Scholar PubMed

[25] Yoshida Y, Kurokawa T, Fukuno N, Nishikawa Y, Kamitani N, Kotsuji F. Markers of apoptosis and angiogenesis indicate that carcinomatous components play an important role in the malignant behavior of uterine carcinosarcoma. Hum Pathol. 2000 Dec;31(12):1448–1454 in Google Scholar PubMed

[26] Jebreel A, England J, Bedford K, Murphy J, Karsai L, Atkin S. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases. Int J Exp Pathol. 2007 Aug;88(4):271–217 in Google Scholar PubMed PubMed Central

[27] Garcia EA, Simões K, Wakamatsu A, Ressio RA, Alves VA, Longatto-Filho A, Camargo RS. Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions. Endocr Pathol. 2010 Jun;21(2):101–107 in Google Scholar PubMed

[28] Cheng L, Bishop E, Zhou H, Maclennan GT, Lopez-Beltran A, Zhang S, Badve S, Baldridge LA, Montironi R. Lymphatic vessel density in radical prostatectomy specimens. Hum Pathol. 2008 Apr;39(4):610–615 in Google Scholar PubMed

[29] Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, Grobholz R. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol. 2004 Jul;172(1):103–107 in Google Scholar PubMed

[30] Gimeno-García AZ, Elwassief AE, Paquin SC, Sahai AV. Endoscopic ultrasound-guided fine needle aspiration cytology and biopsy in the evaluation of lymphoma. Endoscopic Ultrasound. 2012. 2012 May;1(1):17–22 10.7178/eus.01.004Search in Google Scholar PubMed PubMed Central

[31] Eckardt J, Olsen KE, Petersen H. Metastasis in the subcarinal lymph node with unknown primary tumor. Thoracic Cancer. 2011 May;2(2):69–70 in Google Scholar PubMed

[32] Liang Y, Fu D, Hu G. Metadherin: An emerging key regulator of the malignant progression of multiple cancers. Thoracic Cancer 2011 Nov;2(4):143–148 in Google Scholar PubMed

Published Online: 2014-2-13
Published in Print: 2014-4-1

© 2014 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 26.2.2024 from
Scroll to top button